Low-cost, palladium-based nanosheet catalyst matches platinum's performance in hydrogen production
Hydrogen energy is emerging as a key driver of a clean, sustainable future, offering a zero-emission alternative to fossil ...
General Catalyst loses three top investors as the firm expands beyond venture, contemplates IPO
Three key investors have left General Catalyst amidst a series of recent changes at the firm, which now describes itself as ...
General Catalyst is reportedly weighing a potential IPO
General Catalyst, the powerhouse venture firm, is considering an IPO, Axios reported Friday morning, citing "multiple sources ...
High-throughput computing and in situ tech advance atomic catalyst design
A research has developed a method to detect harmful heavy metals through a selective catalytic double metal single atom in ...
Midland Reporter-Telegram on MSN3d
Jacam Catalyst expands into offshore markets with new chemical solutions
Jacam Catalyst is expanding into the offshore market, offering oilfield chemical solutions manufactured at its Gardendale ...
AeroTime4d
Positive sign for Beechcraft Denali as FAA approves GE Aerospace Catalyst engine
The new GE Aerospace Catalyst turboprop engine has been given the seal of approval by the FAA in a positive sign for ...
Catalyst Pharmaceuticals price target raised to $32 from $28 at Baird
Baird raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $32 from $28 and keeps an Outperform rating on the shares. The firm ...
Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges
Catalyst Pharmaceuticals' Firdapse delivers strong growth with a 37% CAGR. Click here to find out why CPRX stock is a Hold.